The C3stau2 exoenzyme from Staphylococcus aureus is a C3-like ADP-ribosyltransferase that ADP-ribosylates not only RhoA-C but also RhoE/Rnd3. In this study we have crystallized and determined the structure of C3stau2 in both its native form and in complex with NAD at 1.68-and 2.02-Å resolutions, respectively. The topology of C3stau2 is similar to that of C3bot1 from Clostridium botulinum (with which it shares 35% amino acid sequence identity) with the addition of two extra helices after strand 1. The native structure also features a novel orientation of the catalytic ARTT loop, which approximates the conformation seen for the "NAD bound" form of C3bot1. C3stau2 orients NAD similarly to C3bot1, and on binding NAD, C3stau2 undergoes a clasping motion and a rearrangement of the phosphate-nicotinamide binding loop, enclosing the NAD in the binding site. Comparison of these structures with those of C3bot1 and related toxins reveals a degree of divergence in the interactions with the adenine moiety among the ADP-ribosylating toxins that contrasts with the more conserved interactions with the nicotinamide. Comparison with C3bot1 gives some insight into the different protein substrate specificities of these enzymes.The family of C3 ADP-ribosyltransferases is a subgroup of the ADP-ribosyltransferase toxins that also include the A-B toxins such as diphtheria toxin and cholera toxin and the binary toxins, which include C2 from Clostridium botulinum, the vegetative insecticidal protein (VIP) 1 from Bacillus cereus, and the Iota toxin from Clostridium perfringens. The targets for the C3 ADP-ribosyltransferases are mammalian Rho GTPases, but they are novel among the ADP-ribosylating toxins in that they lack a cell binding or translocation domain to allow entry into cells, and hence, their role in disease is not yet clear. However, the best-characterized member of this family, the C3 exoenzyme from C. botulinum, C3bot1, has long been used to research the function of the small mammalian GTPases. This is due to its ability to specifically ADP-ribosylate and, therefore, inactivate RhoA, -B, and-C (1) but not the related proteins Rac and Cdc42 (2-4). C3bot1 has been described as the prototype for this family of ADP-ribosyltransferases, which also includes C3 from Clostridium limosium (C3lim) (4), B. cereus (C3cer) (5), and the epidermal differentiation inhibitor (EDIN) (6) from Staphylococcus aureus.The two isoforms of C3 from C. botulinum, known as C3bot1 (7, 8) and C3bot2 (9), have so far been assumed to represent the whole family and have attracted the most research. Recently, however, the existence of a subgroup of the family has emerged with the discovery of two proteins from S. aureus named C3stau2 (or EDIN B) (10 -12) and C3stau3 (or EDIN C) (13). Whereas the C3s from C. botulinum and C. limosium have 63% sequence identity (4), the C3stau exoenzymes have only 35% sequence identity with the clostridial C3s, although they are 65% identical to each other (Fig. 1). Interestingly, C3stau2, and very recently, EDIN (C3stau1) have...